Hypertension

Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension - 2021 NHLBI Workshop Report. 2022

Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 2020.  79:1971-1980. 2022

Blood Pressure Intervention and Control in SPRINT.  79:2071-2080. 2022

Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study.  79:1984-1993. 2022

Insights From a Large-Scale Whole-Genome Sequencing Study of Systolic Blood Pressure, Diastolic Blood Pressure, and Hypertension.  79:1656-1667. 2022

Performance of a Multianalyte 'Rule-Out' Assay in Pregnant Individuals with Suspected Preeclampsia.  79:1515-1524. 2022

Sex Differences in Diurnal Sodium Handling during Diet-Induced Obesity in Rats.  79:1395-1408. 2022

Association of Polygenic Risk Score with Blood Pressure and Adverse Cardiovascular Outcomes in Individuals with Type II Diabetes: Insights from the ACCORD Trial.  79:E100-E102. 2022

Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant Hypertension.  79:775-784. 2022

Multiple social vulnerabilities to health disparities and hypertension and death in the regards study.  79:196-206. 2022

Racial and Ethnic Differences in Blood Pressure Among US Adults, 1999-2018.  78:1730-1741. 2021

Risk-Based Intensive Blood Pressure Lowering and Prevention of Heart Failure: A SPRINT Post Hoc Analysis.  78:1742-1749. 2021

SPRINT Revisited: Updated Results and Implications.  78:1701-1710. 2021

Adherence to Recommended Eating Patterns Is Associated with Lower Risk of Peripheral Arterial Disease: Results from the Women's Health Initiative.  78:447-455. 2021

Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective.  78:555-558. 2021

Blood Pressure Levels in Young Adulthood and Midlife Stroke Incidence in a Diverse Cohort.  77:1683-1693. 2021

Maintaining Normal Blood Pressure Across the Life Course: The JHS.  77:1490-1499. 2021

Coronary Artery Calcium Score for Personalization of Antihypertensive Therapy: A Pooled Cohort Analysis.  77:1106-1118. 2021

Effect of Intensive Versus Standard Blood Pressure Control on Stroke Subtypes.  77:1391-1398. 2021

Connecting Generations of Scientists in the Council on Hypertension Through Harriet Dustan.  77:296-307. 2021

Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion.  77:435-444. 2021

Degradation of Premature-miR-181b by the Translin/Trax RNase Increases Vascular Smooth Muscle Cell Stiffness.  831-839. 2021

Extreme Variability in Urinary Sodium Excretion: Time to Stop Use of Spot Urines to Predict Clinical Outcomes.  1637-1639. 2021

Heart Failure Primary Prevention: What Does SPRINT Add?: Recent Advances in Hypertension.  1804-1814. 2021

Reasons for Uncontrolled Blood Pressure among US Adults: Data from the US National Health and Nutrition Examination Survey.  1567-1576. 2021

Serum Urate Trajectory in Young Adulthood and Incident Cardiovascular Disease Events by Middle Age: CARDIA Study.  1211-1218. 2021

Team Science: American Heart Association's Hypertension Strategically Focused Research Network Experience.  1857-1866. 2021

Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices.  76:1350-1367. 2020

Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.  76:1600-1607. 2020

Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study.  76:1090-1096. 2020

Case of Episodic and Positional Hypertension: Diagnosis and Treatment.  76:614-621. 2020

Mid- to Late-Life Time-Averaged Cumulative Blood Pressure and Late-Life Cardiac Structure, Function, and Heart Failure.  76:808-818. 2020

Fibroblast Growth Factor 23 and Blood Pressure in Older Adults: The Health, Aging, and Body Composition Study.  76:236-243. 2020

Diurnal Control of Blood Pressure Is Uncoupled from Sodium Excretion.  75:1624-1634. 2020

Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation.  75:1491-1496. 2020

Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights from the SPRINT Trial.  75:1483-1490. 2020

Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.  510-515. 2020

Cardiovascular Health and Transition from Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.  1953-1961. 2020

Global Blood Pressure Screening: A Wakeup Call.  318-320. 2020

Noncanonical Mechanisms for Direct Bone Marrow Generating Ang II (Angiotensin II) Predominate in CD68 Positive Myeloid Lineage Cells.  500-509. 2020

Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results from SPRINT.  660-667. 2020

Report of the National Heart, Lung, and blood institute working group on hypertension barriers to translation.  902-917. 2020

Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study.  75:246-256. 2020

Changes in the prevalence of chronic hypertension in Pregnancy, United States, 1970 to 2010.  74:1089-1095. 2019

Sex Differences in Hypertension and Stroke Risk in the REGARDS Study: A Longitudinal Cohort Study.  74:749-755. 2019

Gene Variants at Loci Related to Blood Pressure Account for Variation in Response to Antihypertensive Drugs Between Black and White Individuals..  74:614-622. 2019

Masked uncontrolled hypertension is not attributable to medication nonadherence.  74:652-659. 2019

Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART.  74:276-284. 2019

Gut microbiota composition and blood pressure: The CARDIA study.  73:998-1006. 2019

Blood Pressure and Cognitive Decline over 8 Years in Middle-Aged and Older Black and White Americans.  73:310-318. 2019

Cardiovascular Disease and Mortality in Adults Aged ≥60 Years According to Recommendations by the American College of Cardiology/American Heart Association and American College of Physicians/American Academy of Family Physicians.  73:327-334. 2019

HFE H63D Polymorphism and the Risk for Systemic Hypertension, Myocardial Remodeling, and Adverse Cardiovascular Events in the ARIC Study.  73:68-74. 2019

Out-of-Clinic Sympathetic Activity Is Increased in Patients with Masked Uncontrolled Hypertension.  73:132-141. 2019

Resistant hypertension: Detection, evaluation, and management a scientific statement from the American Heart Association.  72:E53-E90. 2018

Blood pressure patterns and subsequent coronary artery calcification in women who delivered preterm births.  72:159-166. 2018

Case of refractory hypertension controlled after aortic and mitral valve replacement and coronary artery bypass grafting.  72:3-9. 2018

FGF23 (fibroblast growth factor-23) and incident hypertension in young and middle-aged adults: The CARDIA study.  72:70-76. 2018

Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial).  71:848-857. 2018

Accuracy of blood pressure measurement devices in pregnancy: A systematic review of validation studies.  71:326-335. 2018

Impact of intensive versus standard blood pressure management by tertiles of blood pressure in SPRINT (Systolic Blood Pressure Intervention Trial).  71:1064-1074. 2018

Refractory hypertension is not attributable to intravascular fluid retention as determined by intracardiac volumes.  72:343-349. 2018

White-Coat Effect Is Uncommon in Patients with Refractory Hypertension.  70:645-651. 2017

Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries among Older Treated Adults with Hypertension.  70:259-266. 2017

Cardiovascular Health and Incident Hypertension in Blacks :JHS (The Jackson Heart Study).  70:285-292. 2017

Mechanisms and Treatment of Halogen Inhalation-Induced Pulmonary and Systemic Injuries in Pregnant Mice.  70:390-400. 2017

Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.  70:461-468. 2017

Trends in Prehypertension and Hypertension Risk Factors in US Adults 1999-2012.  70:275-284. 2017

Hypertension in Women: Recent Advances and Lingering Questions.  70:19-26. 2017

Distinctive Risk Factors and Phenotype of Younger Patients with Resistant Hypertension: Age is Relevant.  69:827-835. 2017

Hypertension in Blacks: Unanswered Questions and Future Directions for the JHS (Jackson Heart Study).  69:761-769. 2017

Hypertension and Its Complications in a Young Man with Autoimmune Disease.  69:536-544. 2017

Physical activity and incident hypertension in African Americans.  69:421-427. 2017

On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults with Isolated Systolic Hypertension.  69:220-227. 2017

Cardiovascular Risk Factors and Masked Hypertension: The Jackson Heart Study.  68:1475-1482. 2016

Research Needs to Improve Hypertension Treatment and Control in African Americans.  68:1066-1072. 2016

Research needs to improve hypertension treatment and control in African Americans.  68:1066-1072. 2016

Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients with Resistant Hypertension.  68:995-1003. 2016

Trends in antihypertensive medication discontinuation and low adherence among medicare beneficiaries initiating treatment from 2007 to 2012.  68:565-575. 2016

Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study.  68:501-510. 2016

Masked Hypertension and Incident Clinic Hypertension Among Blacks in the Jackson Heart Study.  68:220-226. 2016

The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.  68:39-45. 2016

Visit-to-Visit Variability in Blood Pressure Is Related to Late-Life Cognitive Decline.  68:106-113. 2016

Longitudinal patterns of change in systolic blood pressure and incidence of cardiovascular disease: The atherosclerosis risk in communities study.  67:1150-1156. 2016

Refractory hypertension: A novel phenotype of antihypertensive treatment failure.  67:1085-1092. 2016

Introduction to the American Heart Association's hypertension strategically focused research network.  67:674-680. 2016

Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial.  67:550-555. 2016

Obesity, African American Race, Chronic Kidney Disease, and Resistant Hypertension: The Step beyond Observed Risk.  67:275-277. 2016

SPRINT Trial Results: Latest News in Hypertension Management.  67:263-265. 2016

New Clues Towards Solving the Mystery of Endothelin and Blood Pressure Regulation.  66:275-277. 2015

Determinants of aortic root dilatation and reference values among young adults over a 20-year period: Coronary artery risk development in young adults study.  66:23-29. 2015

Refractory hypertension: Evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure.  66:126-133. 2015

Treatment of Hypertension in Patients with Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.  65:1372-1407. 2015

Should acetaminophen be added to the list of anti-inflammatory agents that are associated with cardiovascular events?.  65:991-992. 2015

Transcription factor avian erythroblastosis virus E26 oncogen homolog-1 is a novel mediator of renal injury in salt-sensitive hypertension.  65:813-820. 2015

Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.  65:385-392. 2015

Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality a systematic review and meta-analysis.  64:965-982. 2014

Determination of prevalence, risk factors, and comorbidities in a large, population-based cohort.  63:451-458. 2014

2013 Dahl Lecture American heart association council for high blood pressure research clarifying the physiology of endothelin.  63. 2014

Adverse childhood experiences are associated with detrimental hemodynamics and elevated circulating endothelin-1 in adolescents and young adults.  64:201-207. 2014

Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: The Reasons for Geographic and Racial Differences in Stroke study.  64:465-471. 2014

Increased reactive oxygen species, metabolic maladaptation, and autophagy contribute to pulmonary arterial hypertension-induced ventricular hypertrophy and diastolic heart failure.  64:1266-1274. 2014

Response to should more significance be granted to medication response to antihypertensives in patients with resistant hypertension?.  63. 2014

Transforming growth factor-β regulates endothelial function during high salt intake in rats.  62:951-956. 2013

Evaluating the Framingham hypertension risk prediction model in young adults: The Coronary Artery risk Development in Young Adults (CARDIA) study.  62:1015-1020. 2013

Differential influence of distinct components of increased blood pressure on cardiovascular outcomes: From the atherosclerosis risk in communities study.  62:492-498. 2013

Renal collecting duct nos1 maintains fluid-electrolyte homeostasis and blood pressure.  62:91-98. 2013

Mortality and morbidity during and after antihypertensive and lipid-lowering treatment to prevent heart attack trial: Results by sex.  61:977-986. 2013

The amiloride-sensitive endothelial sodium channel and vascular tone.  61:952-954. 2013

What are the key arguments against uric acid as a true risk factor for hypertension?.  61:948-951. 2013

Endothelin, kidney disease, and hypertension.  61:1142-1145. 2013

Preterm birth and future maternal blood pressure, inflammation, and intimal-medial thickness: The CARDIA study.  61:641-646. 2013

A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.  61:82-88. 2013

Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II.  60:1226-1233. 2012

Uric acid reduction rectifies prehypertension in obese adolescents.  60:1148-1156. 2012

Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.  59:926-933. 2012

Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.  58:1120-1125. 2011

Isolated diastolic hypotension and incident heart failure in older adults.  58:895-901. 2011

Early life stress enhances angiotensin II-mediated vasoconstriction by reduced endothelial nitric oxide buffering capacity.  58:619-626. 2011

Erratum: Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat (Hypertension (2010) 56 (942-949)).  58. 2011

Uric acid: A clinically useful marker to distinguish preeclampsia from gestational hypertension.  58:548-549. 2011

Role of adenosine 5′-triphosphate in regulating renal microvascular function and in hypertension.  58:333-340. 2011

Sex differences in renal medullary endothelin receptor function in angiotensin ii hypertensive rats.  58:212-218. 2011

Response to intervisit blood pressure variability and outcome: Is heart rate a missing confounder?.  58. 2011

Ethnic differences in hypertension incidence among middle-aged and older adults: The multi-ethnic study of atherosclerosis.  57:1101-1107. 2011

P2X1 receptor-mediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet.  57:780-787. 2011

Mechanisms underlying hypertension and obesity: A melanocortin linkage in the brain.  57:375-376. 2011

High dietary protein exacerbates hypertension and renal damage in dahl SS rats by increasing infiltrating immune cells in the kidney.  57:269-274. 2011

The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: Findings from NHANES III, 1988 to 1994.  57:160-166. 2011

Ethnic differences in hypertension incidence among middle-aged and older adults: The multi-ethnic study of atherosclerosis.  57:1101-1107. 2011

Geographic and demographic variability in 20-year hypertension incidence: The CARDIA study.  57:39-47. 2011

Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans..  58:935-942. 2011

Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat.  56:942-949. 2010

Ethnic Differences in Incident Hypertension among Middle Age and Older Adults: The Multi-Ethnic Study of Atherosclerosis.  56:E88-E88. 2010

Interleukin 6 knockout prevents angiotensin II hypertension: Role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.  56:879-884. 2010

Macrophage migration inhibitory factor in the paraventricular nucleus plays a major role in the sympathoexcitatory response to salt..  56:956-963. 2010

Endothelin activation of reactive oxygen species mediates stress-induced pressor response in dahl salt-sensitive prehypertensive rats.  56:282-289. 2010

Dissecting the complex physiology of endothelin: New lessons from genetic models.  56:31-33. 2010

Joint associations of physical activity and aerobic fitness on the development of incident hypertension: Coronary artery risk development in young adults.  56:49-55. 2010

Response to c-reactive protein and cardiovascular disease: Differences between humans and mice.  56. 2010

Comparison of the framingham heart study hypertension model with blood pressure alone in the prediction of risk of hypertension: The multi-ethnic study of atherosclerosis.  55:1339-1345. 2010

The transcription factor ETS-1 mediates proinflammatory responses and neointima formation in carotid artery endoluminal vascular injury.  55:1381-1388. 2010

Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: A prospective clinical study.  55:1137-1142. 2010

C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.  55:953-960. 2010

Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the zucker obese rat.  55:880-888. 2010

Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction.  55:241-248. 2010

Response to role of epithelial sodium channels in the renal myogenic response?.  55. 2010

Mammalian target of rapamycin: Mastor mediator of cellular changes in pathological states?.  54:1221-1222. 2009

Effect of epithelial sodium channel blockade on the myogenic response of rat juxtamedullary afferent arterioles.  54:1062-1069. 2009

Potassium inhibits dietary salt-induced transforming growth factor-β production.  54:1159-1163. 2009

Phosphate-activated glutaminase-containing neurons in the rat paraventricular nucleus express angiotensin type 1 receptors..  54:845-851. 2009

Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: Results from a randomized trial.  54:475-481. 2009

Hormone therapy of premature ovarian failure the case for "natural" estrogen.  53:745-746. 2009

Dietary salt intake, salt sensitivity, and cardiovascular health.  53:442-445. 2009

Isolated systolic hypertension and incident heart failure in older adults: A propensity-matched study.  53:458-465. 2009

Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute family heart study.  53:473-479. 2009

Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female rats..  53:324-330. 2009

Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease.  53:20-27. 2009

Genetic effect on blood pressure is modulated by age the hypertension genetic epidemiology network study.  53:35-41. 2009

Mysteries of renal autoregulation.  53:299-306. 2009

Dietary salt activates an endothelial proline-rich tyrosine kinase 2/c-Src/phosphatidylinositol 3-kinase complex to promote endothelial nitric oxide synthase phosphorylation.  52:1134-1141. 2008

Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats.  52:1084-1090. 2008

Association between different measures of blood pressure and coronary artery calcium in postmenopausal women.  52:833-840. 2008

Role of endothelin-1 in clinical hypertension: 20 years on.  52:452-459. 2008

Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: A losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.  52:279-286. 2008

Postnatal intermittent hypoxia and developmental programming of hypertension in spontaneously hypertensive Rats: The role of reactive oxygen species and L-Ca ²⁺ channels.  52:156-162. 2008

Thiazide-induced dysglycemia: Call for research from a working group from the national heart, lung, and blood institute.  52:30-36. 2008

Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide.  51:1605-1610. 2008

Effects of losartan in women with hypertension and left ventricular hypertrophy: Results from the Losartan Intervention For Endpoint reduction in hypertension study.  51:1103-1108. 2008

Salt sensitivity: It is not always in the genes.  51:823-824. 2008

Racial differences in microalbumin excretion in healthy adolescents.  51:334-338. 2008

Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension.  51:339-344. 2008

Chemokine receptor 2b inhibition provides renal protection in angiotensin II-salt hypertension.  50:1069-1076. 2007

Prevalence and correlates of left ventricular hypertrophy in the african american study of kidney disease cohort study.  50:1033-1039. 2007

Pulse pressure is an age-independent predictor of stroke development after cardiac surgery.  50:630-635. 2007

Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats.  49:893-901. 2007

β1 integrins modulate β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling.  49:865-872. 2007

Exaggerated cardiovascular stress responses and impaired β-adrenergic-mediated pressor recovery in obese Zucker rats.  48:1109-1115. 2006

Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension.  48:1116-1123. 2006

Is there a new treatment for hypertensive disease in the horizon? Role of soluble guanylate cyclase.  48:822-823. 2006

Response to does arginase activity in vitro represent that in vivo? [2].  48. 2006

Clarifying endothelin type B receptor function.  48:211-212. 2006

Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension.  48:25-26. 2006

Pathways by which dietary salt affects blood pressure and the nervous system.  47:638-639. 2006

Blood pressure reactivity to psychological stress and coronary calcification in the coronary artery risk development in young adults study.  47:391-395. 2006

Knockdown of arginase I restores NO signaling in the vasculature of old rats.  47:245-251. 2006

NOS3 regulation: Renal tubular epithelial cells are not simply large endothelial cells.  47:19-21. 2006

A population association study of angiotensinogen polymorphisms and haplotypes with left ventricular phenotypes.  46:1294-1299. 2005

Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats.  46:806-811. 2005

Impaired Ca²⁺ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension.  46:562-568. 2005

Improvement of blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension.  46:469-470. 2005

Peroxisome proliferator-activated receptor-α activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade.  46:366-371. 2005

Endothelin, angiotensin, and oxidative stress in hypertension.  45:477-480. 2005

Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.  45:580-585. 2005

Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats.  45:406-411. 2005

Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.  45:326-330. 2005

NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1.  45:283-287. 2005

An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension..  46:975-981. 2005

Pulse pressure and coronary atherosclerosis progression in postmenopausal women.  45:53-57. 2005

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study.  45:198-202. 2005

Resurrection of uric acid as a causal risk factor in essential hypertension.  45:18-20. 2005

Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: The Losartan Intervention for Endpoint reduction in hypertension study.  45:46-52. 2005

Effects of NOS3 Glu298Asp polymorphism on hemodynamic reactivity to stress: Influences of ethnicity and obesity.  44:866-871. 2004

Arterial pressure response to the antioxidant tempol and ETB receptor blockade in rats on a high-salt diet.  44:770-775. 2004

Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling.  44:746-750. 2004

Critical role for the α-1B adrenergic receptor at the sympathetic neuroeffector junction.  44:776-782. 2004

Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice.  44:259-263. 2004

Insulin resistance and hypertension: The insulin resistance atherosclerosis study.  43:1324-1331. 2004

Reduced NOS3 Phosphorylation Mediates Reduced NO/cGMP Signaling in Mesenteric Arteries of Deoxycorticosterone Acetate-Salt Hypertensive Rats.  43:1080-1085. 2004

Salt Intake, Endothelial Cell Signaling, and Progression of Kidney Disease.  43:142-146. 2004

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  42:1206-1252. 2003

Endothelin-1 gene LYS198ASN polymorphism and blood pressure reactivity.  42:494-499. 2003

Hormone replacement therapy and inflammation: Interactions in cardiovascular disease.  42:657-663. 2003

A genome-wide scan for urinary albumin excretion in hypertensive families.  42:291-296. 2003

Hyperuricemia in childhood primary hypertension.  42:247-252. 2003

Na⁺/Ca²⁺ exchanger: Target for oxidative stress in salt-sensitive hypertension.  42:363-368. 2003

Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport.  42:195-199. 2003

Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse.  42:88-95. 2003

Functional role of ETB receptors in the renal medulla.  41:1359-1363. 2003

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?.  41:1183-1190. 2003

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Practical implications.  41:1006-1009. 2003

Estrogen depletion increases blood pressure and hypothalamic norepinephrine in middle-aged spontaneously hypertensive rats.  41:1164-1167. 2003

α2A-adrenergic receptors mediate sympathoinhibitory responses to atrial natriuretic peptide in the mouse anterior hypothalamic nucleus.  41:571-575. 2003

Salt-Sensitive Hypertension After Exposure to Angiotensin Is Associated With Inability to Upregulate Renal Epoxygenases.  42:775-780. 2003

Erratum: Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in spontaneously hypertensive rats (Hypertension (2002) 35:2 (202-208)).  40:566. 2002

The Na+/Ca2+ exchanger in salt sensitive hypertension.  40:416-416. 2002

Insulin sensitivity and blood pressure in black and white children.  40:18-22. 2002

Socioeconomic trajectories and incident hypertension in a biracial cohort of young adults.  39:772-776. 2002

Blood pressure and NaCl-sensitive hypertension are influenced by angiotensin-converting enzyme gene expression in transgenic mice.  39:214-218. 2002

Increased dietary salt activates rat aortic endothelium.  39:239-244. 2002

Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure.  39:105-110. 2002

Blood pressure and NaCl-sensitive hypertension are influenced by angiotensin-converting enzyme gene expression in transgenic mice..  39:214-218. 2002

Increased dietary salt activates rat aortic endothelium..  39:239-244. 2002

Interaction of α1-Na,K-ATPase and Na,K,2Cl-cotransporter genes in human essential hypertension.  38:204-209. 2001

Regeneration of the myocardium: A new role in the treatment of ischemic heart disease?.  38:1413-1415. 2001

Agmatine is an autocrine/paracrine inhibitor of pre-synaptic Ca plus plus channels and vasopressin release in vasopressinergic neurons of the hypothalamo-hypophyseal tract.  36:681-681. 2000

E-hypertension: Opening new vistas.  35:538. 2000

Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats..  35:403-408. 2000

Endogenous circulating sympatholytic factor in orthostatic intolerance.  36:553-560. 2000

Evidence for a gene influencing blood pressure on chromosome 17: Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study.  36:477-483. 2000

Long-term telemetric recording of arterial pressure and heart rate in mice fed basal and high nacl diets.  35:R500-R504. 2000

Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males.  35:722-725. 2000

Vascular compression of the rostral ventrolateral medulla in sympathetic mediated essential hypertension.  36:78-82. 2000

Afferent arteriolar vasodilation to the sulfonimide analog of 11,12- epoxyeicosatrienoic acid involves protein kinase A.  33:408-413. 1999

Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection..  33:170-176. 1999

Low-renin and nonmodulating essential hypertension.  34:395-397. 1999

Purinoceptor-mediated calcium signaling in preglomerular smooth muscle cells.  33:195-200. 1999

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension..  32:989-997. 1998

Calcium Mobilization Contributes to Pressure-Mediated Afferent Arteriolar Vasoconstriction.  31:421-428. 1998

Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction..  31:421-428. 1998

Characteristics of 9194 patients with left ventricular hypertrophy: The LIFE study.  32:989-997. 1998

Concordant genetic and physiological data are required for candidate genes (multiple letters).  32:1104-1105. 1998

Hepatic denervation chronically elevates arterial pressure in Wistar- Kyoto rats.  32:46-51. 1998

Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension.  31:1255-1260. 1998

Ultraviolet light may contribute to geographic and racial blood pressure differences [1] (multiple letters).  31:719. 1998

Vascular smooth muscle nitric oxide synthase anomalies in Dahl/Rapp salt-sensitive rats.  31:918-924. 1998

Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function..  30:128-133. 1997

Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca²⁺ from intracellular stores.  29:222-227. 1997

Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function.  30:128-133. 1997

Heritability of left ventricular mass: The Framingham Heart Study.  30:1025-1028. 1997

Long-term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS).  29:8-14. 1997

Role of renal nerves in afferent arteriolar reactivity in angiotensin- induced hypertension.  29:442-449. 1997

Ultraviolet light may contribute to geographic and racial blood pressure differences.  30:150-156. 1997

Acute saline infusion decreases norepinephrine release in the anterior hypothalamic area..  27:578-583. 1996

Atrial natriuretic peptide blunts arterial baroreflex in spontaneously hypertensive rats.  27:297-302. 1996

Genetic association of 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks.  28:478-482. 1996

Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension.  28:335-340. 1996

Acute hypertension increases norepinephrine release in the anterior hypothalamic area..  25:828-833. 1995

Gender and dietary NaCl in spontaneously hypertensive and Wistar-Kyoto rats.  26:285-289. 1995

Salt-induced hypertension in normotensive spontaneously hypertensive rats..  23:791-796. 1994

Analysis of the genetic contamination of salt-sensitive Dahl/Rapp rats.  24:255-259. 1994

Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats.  24:1-7. 1994

Nitric oxide synthase isozymes characterization, purification, molecular cloning, and functions.  23:1121-1131. 1994

Renal apical membrane sodium-hydrogen exchange in genetic salt-sensitive hypertension.  24:491-498. 1994

Renal arteriolar angiotensin responses during varied adenosine receptor activation.  23:I-114-I-119. 1994

Salt-induced hypertension in normotensive spontaneously hypertensive rats.  23:791-796. 1994

Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.  21:660-666. 1993

Coarctation induces alterations in basement membranes in the cardiovascular system.  22:743-753. 1993

Developmental sensitivity to high dietary sodium chloride in borderline hypertensive rats.  22:542-550. 1993

Effects of long-term air jet noise and dietary sodium chloride in borderline hypertensive rats.  22:527-534. 1993

Excitatory sympathetic reflex in NaCl-sensitive spontaneously hypertensive rats.  22:285-291. 1993

Genomic analysis and expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase.  21:934-938. 1993

Nitric oxide mediates immune dysfunction in the spontaneously hypertensive rat.  21:185-194. 1993

Normotensive blacks have heightened sympathetic response to cold pressor test.  22:801-805. 1993

Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats.  22:812-818. 1993

Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats.  19:456-463. 1992

Atrial natriuretic peptide modulates baroreceptor reflex in spontaneously hypertensive rat.  20:374-379. 1992

Attenuated afferent arteriolar response to acetylcholine in goldblatt hypertension.  19:785-789. 1992

Blocking hypothalamic AT1 receptors lowers blood pressure in salt- sensitive rats.  20:755-762. 1992

Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus.  19:475-481. 1992

Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii.  19:198-205. 1992

Quantitation of hypothalamic atrial natriuretic peptide messenger RNA in hypertensive rats.  19:296-300. 1992

Salt supplementation does not alter the pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii.  20:242-246. 1992

High NaCl diet enhances arterial baroreceptor reflex in NaCl-sensitive spontaneously hypertensive rats.  17:363-368. 1991

Intrahypothalamic clonidine infusion prevents NaCl-sensitive hypertension.  18:224-229. 1991

Juxtamedullary afferent arteriolar responses to P1 and P2 purinergic stimulation.  17:1033-1037. 1991

Afferent arteriolar responsiveness to altered perfusion pressure in renal hypertension.  15:748-752. 1990

Atrial natriuretic factor prevents NaCl-sensitive hypertension in spontaneously hypertensive rats.  15:170-176. 1990

Exaggerated natriuretic response to atrial natriuretic factor in rats developing spontaneous hypertension.  16:72-79. 1990

Genetic, neurohumoral, and hemodynamic influences on spontaneously hypertensive rat heart development in oculo.  15:247-256. 1990

Interleukin-2 does not attenuate hypertension in spontaneously hypertensive rats.  16:468-471. 1990

NaCl does not affect hypothalamic noradrenergic input in deoxycorticosterone acetate/NaCl and dahl salt-sensitive rats.  16:55-62. 1990

Atrial natriuretic factor in NaCl-sensitive and NaCl-resistant spontaneously hypertensive rats.  14:404-412. 1989

Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study.  14:218-226. 1989

Impaired reflex response to volume expansion in NaCl-sensitive spontaneously hypertensive rats.  14:518-524. 1989

Renal nerve contribution to NaCl-exacerbated hypertension in spontaneously hypertensive rats.  14:184-190. 1989

Impaired release of atrial natriuretic factor in NaCl-loaded spontaneously hypertensive rats..  11:739-744. 1988

Captopril and the response to stress in the spontaneously hypertensive rat..  11:I144-I147. 1988

Captopril and the response to stress in the spontaneously hypertensive rat.  11:I-144-I-147. 1988

High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats.  11:55-62. 1988

Impaired release of atrial natriuretic factor in NaCl-loaded spontaneously hypertensive rats.  11:739-744. 1988

Exacerbation of hypertension by high chloride, moderate sodium diet in the salt-sensitive spontaneously hypertensive rat..  9:III171-III175. 1987

Exacerbation of hypertension by high chloride, moderate sodium diet in the salt-sensitive spontaneously hypertensive rat.  9:III-171-III-175. 1987

Spontaneously hypertensive rats exhibit reduced hypothalamic noradrenergic input after NaCl loading.  10:313-320. 1987

Ventricular atriopeptin: Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone.  9:485-491. 1987

Atriopeptins as cardiac hormones.  7:469-482. 1985

Hypertension in a 74-year-old man with hydronephrosis and coronary disease principal discussant.  7:824-833. 1985

Hypertension in a 74-year-old man with hydronephrosis and coronary disease..  7:824-833. 1985

Myocardial cell hypertrophy or hyperplasia.  6. 1984

Myocardial cell hypertrophy or hyperplasia.  6:38-43. 1984

Myocardial cell hypertrophy or hyperplasia..  6:III38-III43. 1984

Baseline physical examination characteristics of the hypertensive participants.  5. 1983

Hypertension detection and follow-up program. Baseline medical history characteristics of the hypertensive participants..  5. 1983

Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat.  5:689-700. 1983

Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril.  5:653-662. 1983

Baseline medical history characteristics of the hypertensive participants.  5:51-91. 1983

Baseline physical examination characteristics of the hypertensive participants.  5:92-132. 1983

Kidney function and sodium handling in the pregnant spontaneously hypertensive rat.  5:498-506. 1983

Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.  5:427-435. 1983

Training and certification of blood pressure observers.  5:610-614. 1983

1982: A critical year for hypertension.  4:1-2. 1982

Central effects of prostaglandin E2 on blood pressure and plasma renin activity in rats role of the sympathoadrenal system and vasopressin.  4:809-816. 1982

Decrease in hypothalamic norepinephrine content following renal denervation in the one-kidney, one clip goldblatt hypertensive rat.  4:369-373. 1982

Importance of the renal Nerves in the Pathogenesis of Experimental Hypertension.  4:108-115. 1982

Importance of the renal nerves in established Two-Kidney, one clip goldblatt hypertension.  4:166-174. 1982

Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension..  4:166-174. 1982

Importance of the renal nerves in the pathogenesis of experimental hypertension..  4:III108-III114. 1982

Influence of converting enzyme inhibition on renal hemodynamics and glomerular dynamics in sodium-restricted dogs.  4:58-68. 1982

The role of calcium in the control of renin release.  4:670-675. 1982

A progress report on hypertension.  3:1-3. 1981

Bilateral renal function responses to converting enzyme inhibitor (SQ 20,881) in two-kidney, one clip goldblatt hypertensive rats.  3:285-293. 1981

Clonidine attenuation of a cardiogenic hypertensive chemoreflex.  3:240-244. 1981

Role of the Renal Nerves in the Pathogenesis of One-Kidney Renal Hypertension in the Rat.  3:404-409. 1981

Hemodynamic Response to Vascular Expansion Following Immunosympathectomy in Spontaneously Hypertensive Rats.  2:304-310. 1980

Impact of hypertension information on high blood pressure control between 1973 and 1978.  2:708-713. 1980

Importance of Renal Sympathetic Tone in the Development of DOCA-Salt Hypertension in the Rat.  2:266-273. 1980

The first year of hypertension.  2:1-2. 1980

Glomerular and renal hemodynamics during converting enzyme inhibition (SQ20,881) in the dog.  1:371-377. 1979

Hypertension: A new journal.  1:1-2. 1979

Mechanism of angiotensin i converting enzyme inhibition by SQ20,881 (<Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) in vivo: Further evidence for extrapulmonary conversion.  1:13-22. 1979

Nomenclature for experimental renovascular hypertension. Report of the Nomenclature Committee of the Council for High Blood Pressure Research of the American Heart Association..  1:61. 1979

Regional myocyte size in normotensive and spontaneously hypertensive rats.  1:378-383. 1979